A brand new evaluation is elevating issues about Wegovy, the blockbuster weight-loss drug, after researchers discovered it could carry the best threat of a uncommon “eye stroke” that may trigger sudden imaginative and prescient loss. The examine, primarily based on tens of millions of FDA side-effect stories, discovered the chance sign was practically 5 instances stronger for Wegovy than for Ozempic, regardless of each containing semaglutide.